Cadence captures $100M to expand RPM platform, AI agents - TechTarget

Cadence, a U.S.-based remote patient monitoring company, has secured $100 million in Series C funding led by Spark Capital, with participation from health systems such as Memorial Hermann and Duke Hea... Read original →

Cadence’s $100M raise signals AI-powered remote patient monitoring (RPM) is evolving from a data conduit into an active clinical decision layer. Technologically, its AI agents will drive demand for medical-grade edge MCUs and ultra-low-power BLE 5.3+ SoCs—benefiting Nordic Semiconductor and Texas Instruments. Regulatory risk looms: the FDA’s SaMD framework demands explainable AI and clinician-in-the-loop validation; without it, reimbursement under value-based contracts collapses. Competitors like Current Health and Biofourmis will likely double down on payer partnerships to counter Cadence’s embedded workflow advantage within systems like Duke Health. Over the next 18 months, RPM platforms lacking CPT III coding alignment or ACO risk-sharing integration will fade, while those delivering closed-loop, reimbursable interventions will dominate chronic care—finally anchoring digital therapeutics in real-world clinical pathways.